The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Siemens Healthineers (SMMNY) introduced Accela, a radiotherapy system for single breath-hold stereotactic treatments and multi-site stereotactic body radiotherapy (SBRT).
Built around NeoArc dynamic modulated arc therapy (DMAT), Accela enables multi-site SBRT treatment in as little as 60 seconds.
Details
News Market Reaction – SMMNY
On Sep 28, the first trading day after this news, SMMNY closed 2.41% above the previous close.
Data tracked by StockTitan Argus for the Sep 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT), a breakthrough technique combining speed and precision
Boston, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers introduces Accela, the first radiotherapy system that allows for single breath-hold stereotactic treatments and enables multi-site SBRT treatment in as little as 60 seconds, significantly shortening patient time on the treatment table and the course of treatment.
Contact Info
Julie Gibson
julie.gibson@siemens-healthineers.com
+1 917-929-5779
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How fast can Siemens Healthineers' Accela deliver multi-site SBRT treatment?
Accela enables multi-site stereotactic body radiotherapy (SBRT) treatment in as little as 60 seconds. It also allows single breath-hold stereotactic treatments.